+8.8%
O vs MRNA
+697.5%
-688.8%
-18.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.6% | -2.2% | +2.8% | +0.7% |
| 7D | -1.3% | -12.7% | +11.4% | -1.3% |
| 30D | +5.3% | -20.7% | +26.0% | +5.4% |
| 3M | -6.8% | +46.3% | -53.1% | -7.1% |
| 6M | -4.2% | +305.2% | -309.4% | -5.5% |
| YTD | +7.6% | +561.2% | -553.6% | +4.5% |
| 1Y | +8.8% | +772.1% | -763.3% | +4.6% |
| All | +8.8% | +697.5% | -688.8% | +4.6% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling